InsidersTradesSigma
MapLight Therapeutics, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the MapLight Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was reported on 20 July 2026 (Cession). Among the most active insiders: GILLIS JONATHAN. The full history is openly available.
119
Insider Decl.
n/a
Thresholds
€369,455
2 ops.
Buy Volume
€14m
75 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate MapLight Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$41.50.
40Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 July 2026
Declarations119 total
5,356 shares@ US$36.13Voting Common StockSEC:0001709954-26-000010:0
4,699 shares@ US$36.94Voting Common StockSEC:0001709954-26-000010:1
6,979 shares@ US$36.66Voting Common StockSEC:0001709954-26-000010:2
1,476 shares@ US$37.44Voting Common StockSEC:0001709954-26-000010:3
600 shares@ US$36.51Voting Common StockSEC:0001709954-26-000010:4
16,969 shares@ US$37.61Voting Common StockSEC:0001709954-26-000010:5
900 shares@ US$38.17Voting Common StockSEC:0001709954-26-000010:6
5,545 shares@ US$36.13Voting Common StockSEC:0002021238-26-000010:0
4,510 shares@ US$36.94Voting Common StockSEC:0002021238-26-000010:1
7,464 shares@ US$36.66Voting Common StockSEC:0002021238-26-000010:2
1,592 shares@ US$37.44Voting Common StockSEC:0002021238-26-000010:3
2,833 shares@ US$37.05Voting Common StockSEC:0002021238-26-000010:4
14,140 shares@ US$37.70Voting Common StockSEC:0002021238-26-000010:5
200 shares@ US$38.39Voting Common StockSEC:0002021238-26-000010:6
17,173 shares@ US$37.220.037% mcap100.0% of flowCommonSEC144:0001950047-26-007189
18,469 shares@ US$37.220.040% mcap100.0% of flowCommonSEC144:0001950047-26-007188
5,103 shares@ US$36.990.011% mcap10.9% of flowVoting Common StockSEC:0001789970-26-000012:1
11 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001789970-26-000012:5
8,972 shares@ US$36.990.019% mcap7.5% of flowVoting Common StockSEC:0002021233-26-000012:3
3,656 shares@ US$37.900.0081% mcap3.1% of flowVoting Common StockSEC:0002021233-26-000012:8
4,776 shares@ US$36.450.010% mcap10.0% of flowVoting Common StockSEC:0001789970-26-000012:3
5,009 shares@ US$36.450.011% mcap8.0% of flowVoting Common StockSEC:0001728746-26-000012:3
12 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001728746-26-000012:5
7,155 shares@ US$36.160.015% mcap5.9% of flowVoting Common StockSEC:0002021233-26-000012:0
7,845 shares@ US$37.040.017% mcap6.6% of flowVoting Common StockSEC:0002021233-26-000012:1
25 of 119 declarations
Acerca de MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. es una empresa enfocada en el desarrollo de terapias innovadoras para el tratamiento de enfermedades neurológicas. Cotiza en NASDAQ bajo el ticker XNAS.